The DOI matches its Crossref record.
Progestin regulation of cellular proliferation.
Abstract
THE control of cellular proliferation is known to involve a delicate balance between the effects of different regulatory molecules including hormones and growth factors which provide, in the immediate environment of the cell, signals to stimulate or inhibit cellular replication (1). The past decade has seen significant progress in the identification and characterization of novel regulatory molecules, generally referred to as growth factors, and definition of their molecular mechanisms of action (2, 3). With the recent emphasis on peptide growth factors it is perhaps less well appreciated that some of the largest physiological changes (both positive and negative) in rates of growth and cell proliferation are mediated by steroid hormones. Recent studies on breast cancer cells (4) and immature rat uterus (5, 6), illustrating estrogenic control of autocrine and paracrine growth factor production, support the view that some of these steroid-induced responses are intimately linked to growth factor-mediated pathways although debate continues as to whether the growth factor response is the cause, or the consequence, of the estrogenic effect on cellular proliferation (7, 8). Generally speaking, the molecular mechanisms by which steroid hormones control proliferation are not well defined, with the most developed knowledge being in the area of estrogen action where a number of recent reviews are available (4, 9–11).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“recent data suggest that progestins exert a negative impact on breast cancer (2-5), with recent reports indicating an increased risk of the disease in women (6,7).”
Citations
Cited by
Sorted by citations
Items 301–400 of 660
Expression of progesterone and oestrogen receptors by early intrauterine equine conceptuses
Rambags, B. P. B., van Tol, H. T. A., van den Eng, M. M., Colenbrander, B., & Stout, T. A. E. (2007) · Theriogenology · doi:10.1016/j.theriogenology.2007.10.011 · Cited by 35
“Progesterone and oestrogen play important roles in conceptus development and, until fairly recently, it was widely accepted that their effects were indirect and mediated almost exclusively by modulation of endometrial receptivity [1–4].”
BackgroundAffinito, P., Carlo, C. D., Mauro, P. D., et al. (1994) · Maturitas · doi:10.1016/0378-5122(94)90016-7 · Cited by 35
Contraceptive steroids and the mammary gland: Is there a hazard?
Rutteman, G. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01831473 · Cited by 35
“Part of this mitogenic effect of progesterone may be the result of effects induced in the stroma [76,96,97].”
BackgroundCampagnoli, C., Biglia, N., Peris, C., & Sismondi, P. (1995) · Gynecological Endocrinology · doi:10.3109/09513599509160194 · Cited by 35
Šauer, P., Tumová, J., Steinbach, C., Golovko, O., Komen, H., Maillot‐Maréchal, E., Machová, J., Grabic, R., Aı̈t-Aı̈ssa, S., & Kroupová, H. K. (2019) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2019.109912 · Cited by 33
Kim, T. H., Lee, D.-K., Franco, H. L., et al. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.109.081307 · Cited by 34
“P4 is an essential regulator in the uterus during pregnancy [5, 6].”
BackgroundSathi, P., Kalyan, S., Hitchcock, C. L., Pudek, M. R., & Prior, J. C. (2012) · Clinical Endocrinology · doi:10.1111/cen.12128 · Cited by 34
Prior, J. C., & Hitchcock, C. L. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.705390 · Cited by 34
“Progesterone increases breast cell proliferation [25] but only briefly before it converts to cause differentiation and cell maturation.”
BackgroundGandhi, A., Holland, P., Knox, W. F., Potten, C. S., & Bundred, N. J. (2000) · PubMed · Cited by 34
Reproductive Functions of the Progesterone Receptor
Conneely, O. M., Lydon, J. P., Mayo, F. J. D., & O’Malley, B. W. (2000) · Journal of the Society for Gynecologic Investigation · doi:10.1177/1071557600007001s09 · Cited by 36
Influence of ovarian steroids on relaxin-induced uterine growth in ovariectomized gilts.
Hall, J. A., Cantley, T. C., Galvin, J., et al. (1992) · Endocrinology · doi:10.1210/endo.130.6.1597136 · Cited by 34
Lecanda, J., Parekh, T. V., Gama, P., Lin, K., Liarski, V. M., Uretsky, S., Mittal, K., & Gold, L. I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0235 · Cited by 33
“E2 was added together with progesterone to increase the level of progesterone receptors for a more robust response (35).”
BackgroundTherapeutic Effects of Progesterone in Animal Models of Neurological Disorders
Nicola, A. F. D., Coronel, F. A., Garay, L. I., Gargiulo-Monachelli, G. M., Deniselle, M. C. G., Sl, G. L., Labombarda, F., Meyer, M., Guennoun, R., & Schumacher, M. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152731131200120 · Cited by 36
Pok, S., Barn, V., Wong, H. J., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13232 · Cited by 33
Bhatti, S. F. M., Rao, N., Okkens, A. C., Mol, J. A., Duchateau, L., Ducatelle, R., van den Ingh, T. S. G. A. M., Tshamala, M., Ham, L. M. L. V., Coryn, M., et al. (2006) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2006.06.005 · Cited by 33
“An increase in plasma progesterone concentration results in a decline of PR content in the uterus [55–59] and explains the decrease of PR mRNA with MPA treatment in the present study.”
BackgroundSager, G., Ørbo, A., Jæger, R., & Engström, C. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00269-8 · Cited by 33
Campagnoli, C., Biglia, N., Lanza, M., Lesca, L., Peris, C., & Sismondi, P. (1994) · Maturitas · doi:10.1016/0378-5122(94)90038-8 · Cited by 33
Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer
Hou, Z., Huang, S., Mei, Z., Chen, L., Guo, J., Gao, Y., Zhuang, Q., Zhang, X., Tan, Q., Yang, T., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100561 · Cited by 33
“It binds to the PR and regulates fetus implantation and other essential physiological functions.(46) Progesterone and the PR have been reported as preventive factors in breast, colon, and lung cancer.”
BackgroundBosschere, H. D., Ducatelle, R., & Tshamala, M. (2002) · Reproduction in Domestic Animals · doi:10.1046/j.1439-0531.2002.00358.x · Cited by 32
The role of Estrogen, Progesterone and Aromatase in Human Non-Small-Cell Lung Cancer
Kazmi, N., Márquez‐Garbán, D. C., Aivazyan, L., Hamilton, N. M., Garon, E. B., Goodglick, L., & Pietras, R. J. (2012) · Lung Cancer Management · doi:10.2217/lmt.12.44 · Cited by 32
Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer
Fanelli, M. A., Vargas-Roig, L. M., Gago, F. E., et al. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806503 · Cited by 32
“It has been reported that the direct growthstimulatory effects of progestins on human breast cancer cells were masked in presence of estrogen and serum [ 48 ].”
BackgroundXu, Y., Klein‐Hitpaß, L., & Bagchi, M. K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2138-2146.2000 · Cited by 32
“The steroid hormone progesterone profoundly influences the development and function of tissues such as the uterus, ovary, mammary gland, and brain (6, 13, 35, 49).”
BackgroundVarayoud, J., Ramos, J. G., Monje, L. D., et al. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06099 · Cited by 31
“It has been shown in the rat uterus that progesterone (P4) selectively decreases ligand-bound ER and inhibits recovery of ER at transcriptional and translational levels ( Clarke & Sutherland 1990 ).”
BackgroundProgesterone prevents radiation-induced apoptosis in breast cancer cells
Varès, G., Ory, K., Lectard, B., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207601 · Cited by 31
“Specifically, steroid hormones, estrogen and progesterone, are responsible for some of the most important physiological changes (Clarke and Sutherland, 1990).”
BackgroundProgestin modulation of c-fos and prolactin gene expression in the human endometrium
dos Reis, F. M., Maia, A. L., Ribeiro, M. F. M., et al. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00138-7 · Cited by 31
Conneely, O. M., & Jericevic, B. M. (2002) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1020020308980 · Cited by 31
Labrie, F., Elalfy, M., Berger, L., Labrie, C., Martel, C., Bélanger, A., Candas, B., & Pelletier, G. (2003) · Endocrinology · doi:10.1210/en.2003-0269 · Cited by 31
Critical Tumor Suppressor Function Mediated by Epithelial Mig-6 in Endometrial Cancer
Kim, T. H., Lee, D.-K., Cho, S.-N., Orvis, G. D., Behringer, R. R., Lydon, J. P., Ku, B. J., McCampbell, A. S., Broaddus, R. R., & Jeong, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0241 · Cited by 32
Skjefstad, K., Richardsen, E. H., Dønnem, T., Andersen, S., Kiselev, Y., Grindstad, T., Hald, S. M., Al-Shibli, K. I., Bremnes, R. M., Busund, L., et al. (2015) · Steroids · doi:10.1016/j.steroids.2015.01.020 · Cited by 30
“Progesterone inhibits proliferation and promotes differentiation of the female reproductive tissues by binding to and activating the progesterone receptor (PR) [5].”
Ogle, T. F. (2002) · Steroids · doi:10.1016/s0039-128x(01)00137-4 · Cited by 30
The molecular basis of tamoxifen induction of mouse uterine epithelial cell proliferation
Zhang, H., McElrath, T., Tong, W., et al. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05987 · Cited by 30
“This results in the sequential phosphorylation of the central cell cycle regulatory molecule, pRb, and progression into S-phase (Clarke & Sutherland 1990, Tong & Pollard 2002, Doisneau-Sixou et al. 2003).”
BackgroundInfluentialHormone replacement therapy and risk of breast cancer: the role of progestins
Stahlberg, C. I., Pedersen, A. T., Lynge, E., & Ottesen, B. (2003) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2003.00551.x · Cited by 30
Hormone replacement therapy in the menopause: a pro opinion
Smith, H. O., KAMMERER-DOAK, D. N., Barbo, D. M., & Sarto, G. E. (1996) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.46.6.343 · Cited by 30
Xie, M., You, S., Chen, Q., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2336 · Cited by 29
“By contrast, progesterone generally promotes differentiation and inhibits cellular proliferation through the nuclear progesterone receptor (nPR) (4).”
Novel Therapeutic Strategies for Malignant Salivary Gland Tumors: Lessons Learned from Breast Cancer
Murase, R., Sumida, T., Ishikawa, A., Murase, R., McAllister, S. D., Hamakawa, H., & Desprez, P. (2011) · International Journal of Otolaryngology · doi:10.1155/2011/187623 · Cited by 29
“The function of sex steroid hormone receptors in breast cancer has been extensively studied and applied to diagnosis and treatment [1, 2].”
Background16α-Hydroxyprogesterone: Origin, biosynthesis and receptor interaction
Storbeck, K., Swart, P., Africander, D., Conradie, R., Toit, R. L.-D., & Swart, A. C. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.016 · Cited by 28
Mineralocorticoid insufficiency due to suramin therapy
Kobayashi, K., Weiss, R. E., Vogelzang, N. J., Vokes, E. E., Janisch, L. A., & Ratain, M. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961201)78:11 · Cited by 28
The role of TGF‐β production in growth inhibition of breast‐tumor cells by progestins
Kalkhoven, E., Kwakkenbos‐Isbrücker, L., Mummery, C. L., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610114 · Cited by 29
Singh, S., Hota, D., Prakash, A., KHANDUJA, K. L., Arora, S. K., & Chakrabarti, A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.10.003 · Cited by 28
Ørbo, A., Arnes, M., Pettersen, I., et al. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349.2010.512068 · Cited by 28
“The understanding that progestins are mediating their effects via classical regulating target genes after binding to nuclear receptors, progesterone receptors (PRs), has been commonly accepted (7).”
BackgroundAlkhalaf, M., El‐Mowafy, A. M., & Karam, S. M. (2002) · European Journal of Cancer Prevention · doi:10.1097/00008469-200210000-00011 · Cited by 28
“Progestins are known to regulate the proliferation of hormone target tissues (e.g. uterus and breast) in both in vitro and in vivo systems (Clarke and Sutherland, 1990), and are used routinely as an endocrine therapy of human breast cancer (Santen et al., 1990).”
InfluentialMottier, V., Siaussat, D., Bozzolan, F., Auzoux-Bordenave, S., Porcheron, P., & Debernard, S. (2003) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2003.09.003 · Cited by 28
Estrogen with interrupted progestin HRT: a review of experimental and clinical studies
Casper, R. F. (2000) · Maturitas · doi:10.1016/s0378-5122(99)00076-6 · Cited by 28
Ogle, T. F., Dai, D., George, P., et al. (1998) · Biology of Reproduction · doi:10.1095/biolreprod58.5.1188 · Cited by 28
Ganesan, K., Balachandran, C., Manohar, B. M., & Puvanakrishnan, R. (2011) · Rheumatology International · doi:10.1007/s00296-011-2146-x · Cited by 27
“by downregulation of cytoplasmic and nuclear estrogen receptor concentrations [29].”
BackgroundMolecular Mechanism of Progesterone-Induced Antiproliferation in Rat Aortic Smooth Muscle Cells
Lee, W., Liu, C.-W., Juan, S., Liang, Y., Ho, P.-Y., & Lee, Y. (2003) · Endocrinology · doi:10.1210/en.2003-0045 · Cited by 27
Progestin-induced Mammary Growth Hormone (GH) Production
Mol, J. A., Leeuwen, I. S. L., van Garderen, E., & Rijnberk, A. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46832-8_8 · Cited by 27
Miller, M. M., James, R. A., Richer, J. K., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4239 · Cited by 27
Dai, D., Albitar, L., Nguyen, T., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.169.4.1 · Cited by 27
“Whereas each isoform controls a unique cadre of genes (12–15), they function together to enhance endometrial differentiation (19, 20).”
BackgroundAngiogenesis as a biologic and prognostic indicator in human breast carcinoma
Engels, K., Fox, S. B., & Harris, A. L. (1997) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0348-9006-9_6 · Cited by 26
Reproductive functions of progesterone
Al‐Asmakh, M. (2008) · Bioline International (Bioline International) · Cited by 26
Prior, J. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.893889 · Cited by 28
“Women’s health concepts today primarily focus on estradiol (E2) and its admittedly strong and important growthstimulating actions in every cell in the body (38).”
BackgroundLontay, B., Bodoor, K., Sipos, A., Weitzel, D. H., Loiselle, D. R., Safi, R., Zheng, D., DeVente, J., Hickner, R. C., McDonnell, D. P., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658120 · Cited by 27
“In accordance with this mechanism, it was reported that both ER and PR mutually regulate each others’ expression through transcriptionally controlled feedback mechanisms (19).”
BackgroundeTasaki, H. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00082 · Cited by 27
Salmi, A. (1998) · Molecular Human Reproduction · doi:10.1093/molehr/4.12.1110 · Cited by 26
Mariani, A., Sebo, T. J., Katzmann, J. A., et al. (2005) · PubMed · Cited by 26
Bamberger, A., Bamberger, C. M., Wald, M., et al. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03895-6 · Cited by 26
Park-Sarge, O. K., & Sarge, K. D. (1995) · Endocrinology · doi:10.1210/endo.136.12.7588292 · Cited by 26
Paulson, E., & Comizzoli, P. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab001 · Cited by 27
Prior, J. C., Cameron, A., Fung, M., Hitchcock, C. L., Janssen, P. A., Lee, T., & Singer, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-35826-w · Cited by 33
Progesterone inhibits human endothelial cell proliferation through a p53-dependent pathway
Hsu, S., Ho, P. Y., Juan, S., Liang, Y., & Lee, W.-S. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8441-3 · Cited by 26
Hirata, M., He, P. J., Shibuya, N., Uchikawa, M., Yamauchi, N., Hashimoto, S., & Hattori, M. A. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9981-4 · Cited by 25
“P4 plays a pivotal role in proliferation of stromal cells and acts as the switch for the decidualization process [33, 34].”
BackgroundProgesterone receptor gene expression in preimplantation pig embryos
Ying, C., Yang, Y., Hong, W., et al. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430697 · Cited by 25
Gregoraszczuk, E. Ł., Milewicz, T., Kołodziejczyk, J., et al. (2001) · Gynecological Endocrinology · doi:10.1080/gye.15.4.251.258 · Cited by 25
Novel Mechanisms of Antiprogestin Action
Horwitz, K. B. (1996) · Acta Oncologica · doi:10.3109/02841869609098493 · Cited by 25
Hormones and receptors in endometrial cancer
Bender, D., Buekers, T., & Leslie, K. K. (2011) · Proceedings in Obstetrics and Gynecology · doi:10.17077/2154-4751.1098 · Cited by 25
Periyasamy‐Thandavan, S., Takhar, S., Singer, A. D., Dohn, M. R., Jackson, W. H., Welborn, A. E., LeRoith, D., Marrero, M. B., Thangaraju, M., Huang, S., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3153 · Cited by 24
“Our studies are based on the hypothesis that targeting PR along with ER should more effectively reduce breast cancer cell growth than does treatment with an antiestrogen, because progesterone, like estrogen, is mitogenic in the breast [53] and drives mammary tumor proliferation in multiple model systems.”
BackgroundDivergent mechanisms for trophic actions of estrogens in the brain and peripheral tissues
Walf, A. A., Paris, J. J., Rhodes, M. E., Simpkins, J. W., & Frye, C. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.11.081 · Cited by 26
“It is not surprising that important biological functions, such as reproduction and behaviors that may support successful reproduction (e.g. affect, cognition, stress responding), would have multiple targets and, even, interact (e.g. E2 induction of PRs).”
BackgroundInfluentialZhao, L., Isayama, K., Chen, H., Yamauchi, N., Shigeyoshi, Y., Hashimoto, S., & Hattori, M. (2016) · Physiological Reports · doi:10.14814/phy2.12663 · Cited by 23
“In rodents and humans, the uterus endometrial stromal cells (UESCs) undergo proliferation and differentiation into decidual cells in response to ovarian steroids and blastocyst implantation at the early stage of pregnancy (Clarke and Sutherland 1990; Zhang et al. 1994; Dey et al. 2004).”
BackgroundAhn, J. I., Yoo, J., Kim, T. H., Kim, Y. I., Ferguson, S. D., Fazleabas, A. T., Young, S. L., Lessey, B. A., Ahn, J., Lim, J. M., et al. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160225153659 · Cited by 25
“P4-PR signaling is critical to implantation, decidualization, and glandular development [3, 37].”
BackgroundBriese, J., Schulte, H. M., Bamberger, C. M., et al. (2006) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000189243.49522.ae · Cited by 24
“unopposed estrogenic stimulation on the basis of endometrial hyperplasias (1,34).”
BackgroundIshida, M., Chang, K., Hirabayashi, K., Nishihara, M., & Takahashi, M. (1999) · Journal of Reproduction and Development · doi:10.1262/jrd.45.321 · Cited by 24
“It is recognized that progesterone exerts cytotoxic effects on proliferation of several cell types [27].”
BackgroundEstrogen causes cell death of estrogen receptor stably transfected cells via apoptosis
Lee, Y., Renaud, R. A., Friedrich, T. C., et al. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00128-9 · Cited by 24
Progesterone-Growth Factor Interactions in Uterine Stromal Cells1
Rider, V., Kimler, B. F., & Justice, W. M. (1998) · Biology of Reproduction · doi:10.1095/biolreprod59.3.464 · Cited by 24
Molecular biology of breast carcinoma
El‐Ashry, D., & Lippman, M. E. (1994) · World Journal of Surgery · doi:10.1007/bf00348187 · Cited by 24
“Originally progestins were thought to be growthinhibitory, as they are in the uterus; but pr0gestins in conjunction with estrogen also cause increased cell growth [ 87 ].”
BackgroundFujimoto, M., Kanzaki, H., Nakayama, H., et al. (1996) · Endocrinology · doi:10.1210/endo.137.3.8603579 · Cited by 24
Stimulatory and inhibitory growth factors and breast cancer
Dickson, R. B. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90422-h · Cited by 24
Characterization and regulation of estrogen and progesterone receptors in breast cancer
Read, L. D., & Katzenellenbogen, B. S. (1991) · Cancer treatment and research · doi:10.1007/978-1-4615-3500-3_14 · Cited by 24
Progesterone receptors and Sp/Krüppel-like family members in the uterine endometrium
Rosalia, C. M. S. (2002) · Frontiers in bioscience · doi:10.2741/simmen · Cited by 23
“The profound effects of progesterone on cell growth, development, differentiation, and homeostasis are mediated through its specific nuclear receptor, a ligand-activated transcription factor (1).”
BackgroundChen, S. X., de Almeida, F. L., Andersson, E., et al. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.07.022 · Cited by 23
Eden, J. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.07.012 · Cited by 24
Puricelli (2010) · Oncology Reports · doi:10.3892/or_00000990 · Cited by 26
Honoré, L. H., Hanson, J., & Andrew, S. (2006) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-00009577-200605000-00067 · Cited by 23
Campagnoli, C., Lesca, L., Cantamessa, C., & Peris, C. (1993) · Maturitas · doi:10.1016/0378-5122(93)90027-f · Cited by 23
Labrie, F., Labrie, C., BÉLANGER, A., Giguère, V., Simard, J., Mérand, Y., Gauthier, S., Luu-The, V., Candas, B., Martel, C., et al. (2001) · Advances in protein chemistry · doi:10.1016/s0065-3233(01)56009-x · Cited by 22
Do Progestogens Reduce The Risk of Breast Cancer? A Review of the Evidence
Wren, B. G., & Eden, J. (1996) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-199603010-00003 · Cited by 23
Schoonen, W. G. E. J., Joosten, J. W. H., & Kloosterboer, H. J. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00216-2 · Cited by 23
Hormonal prevention of breast cancer: proposal for a change in paradigm
Hesch, R. ‐., & Kenemans, P. (1999) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08106.x · Cited by 23
Machado, A. D. B., dos Reis, V. M. S. F., Weber, S. F., Jauckus, J., Brum, I. S., Corleta, H. V. E., Strowitzki, T., Capp, E., & Germeyer, A. (2016) · Oncology Letters · doi:10.3892/ol.2016.5041 · Cited by 22
“Unopposed estrogen has been shown to increase the risk of EC development, as estrogens stimulate endometrial cell proliferation and inhibit apoptosis (3).”
Animal models of human breast carcinoma: canine and feline neoplasms
Mulas, J. M. D. L., & Reymundo, C. (2000) · Revista de Oncología · doi:10.1007/bf02979590 · Cited by 22
Liu, Z., Zhang, X., Zhang, Y., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.044 · Cited by 22
Rapid down-regulation of CD63 transcription by progesterone in human endometrial stromal cells
Okada, H. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.6.554 · Cited by 22
Characterization of a Truncated Progesterone Receptor Protein in Breast Tumors1
Yeates, C., Hunt, S. M. N., Balleine, R. L., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4531 · Cited by 22
Self-citationOgle, T. F., George, P., & Dai, D. (1998) · Biology of Reproduction · doi:10.1095/biolreprod59.2.444 · Cited by 22
The biology of human breast epithelial progenitors
Raouf, A., Sun, Y., Chatterjee, S., & Basak, P. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.04.009 · Cited by 21
Role of Progesterone Receptor Polymorphisms in the Recurrent Spontaneous Abortions: Indian Case
Aruna, M., Nagaraja, T., Andal, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008712 · Cited by 21
Huuskonen, H., Saastamoinen, V., Komulainen, H., et al. (2000) · Reproductive Toxicology · doi:10.1016/s0890-6238(00)00110-6 · Cited by 21
Chapter 2 Progesterone Receptor Action in Leiomyoma and Endometrial Cancer
Kim, J. J., Sefton, E. C., & Bulun, S. E. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)87002-6 · Cited by 21
Wiebe, J. P., & Muzia, D. (2001) · Endocrine · doi:10.1385/endo:16:1:07 · Cited by 21
Breast Cancer: Influence of Endocrine Hormones, Growth Factors and Genetic Alterations
Dickson, R. B., Johnson, M. D., El‐Ashry, D., et al. (1993) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2926-2_10 · Cited by 21
Metadata
- Authors
- CLARKE, C. L., & SUTHERLAND, R. L.
- Affiliations
- Garvan Institute of Medical Research (AU)
- Corresponding author
- SUTHERLAND, ROBERT L.
- ORCID
- CLARKE, CHRISTINE L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1990-05
- Volume
- 11
- Issue
- 2
- Pages
- 266-301
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2056357500
- Cited by
- 650
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 9 · 2021: 7 · 2020: 5 · 2019: 7 · 2018: 6 · 2017: 10 · 2016: 12 · 2015: 18 · 2014: 12 · 2013: 15 · 2012: 21
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- progestins, cell proliferation, steroid hormones, growth factors, estrogen, breast cancer cells, immature uterus, autocrine and paracrine signaling, cell cycle regulation
- MeSH terms
- Animals, Haplorhini, Cell Division, Chickens, Humans, Progestins, Rabbits, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review